Immunohistochemistry cannot replace DNA analysis for evaluation of BRAF V600E mutations in papillary thyroid carcinoma

INTRODUCTION: The BRAF V600E mutation is the most common genetic event occurring in papillary thyroid cancer (PTC). Recently, the possibility of using immunohistochemistry (IHC) to detect the BRAF V600E mutation has been reported. MATERIALS AND METHODS: In 140 patients with classical PTC, the status...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Szymonek, Monika, Kowalik, Artur, Kopczyński, Janusz, Gąsior-Perczak, Danuta, Pałyga, Iwona, Walczyk, Agnieszka, Gadawska-Juszczyk, Klaudia, Płusa, Agnieszka, Mężyk, Ryszard, Chrapek, Magdalena, Góźdź, Stanisław, Kowalska, Aldona
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2017
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5650387/
https://ncbi.nlm.nih.gov/pubmed/29088832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20451
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi